Cargando…

Zonisamide Ameliorates Microglial Mitochondriopathy in Parkinson’s Disease Models

Mitochondrial dysfunction and exacerbated neuroinflammation are critical factors in the pathogenesis of both familial and non-familial forms of Parkinson’s disease (PD). This study aims to understand the possible ameliorative effects of zonisamide on microglial mitochondrial dysfunction in PD. We pr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tada, Satoshi, Choudhury, Mohammed E., Kubo, Madoka, Ando, Rina, Tanaka, Junya, Nagai, Masahiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8870529/ https://www.ncbi.nlm.nih.gov/pubmed/35204031 http://dx.doi.org/10.3390/brainsci12020268

Ejemplares similares

Chloride Intracellular Channel Protein 2 Promotes Microglial Invasion: A Link to Microgliosis in the Parkinson’s Disease Brain
por: Choudhury, Mohammed E., et al.
Publicado: (2022)

A cytokine mixture of GM-CSF and IL-3 that induces a neuroprotective phenotype of microglia leading to amelioration of (6-OHDA)-induced Parkinsonism of rats
por: Choudhury, Mohammed Emamussalehin, et al.
Publicado: (2011)

Mitochondrial Medicine and the Neurodegenerative Mitochondriopathies
por: Swerdlow, Russell H.
Publicado: (2009)

Nightmare-Enacting Behavior Responding to Zonisamide in Early Parkinson's Disease
por: Kataoka, Hiroshi, et al.
Publicado: (2012)

Chromium and cobalt intoxication mimicking mitochondriopathy
por: Rattay, Tim W., et al.
Publicado: (2021)

Zonisamide ameliorates progression of cervical spondylotic myelopathy in a rat model
por: Kanbara, Shunsuke, et al.
Publicado: (2020)

Molecular oncology focus - Is carcinogenesis a 'mitochondriopathy'?
por: Czarnecka, Anna M, et al.
Publicado: (2010)

Zonisamide for the Treatment of Parkinson Disease: A Current Update
por: Li, Chengqian, et al.
Publicado: (2020)

Genome-wide association study identifies zonisamide responsive gene in Parkinson’s disease patients
por: Cha, Pei-Chieng, et al.
Publicado: (2020)

Cytoplasmic hybrid (cybrid) cell lines as a practical model for mitochondriopathies
por: Wilkins, Heather M., et al.
Publicado: (2014)

Zonisamide effects on sleep problems and depressive symptoms in Parkinson’s disease
por: Suzuki, Keisuke, et al.
Publicado: (2021)

Is Long COVID Syndrome a Transient Mitochondriopathy Newly Discovered: Implications of CPET
por: Sakellaropoulos, Stefanos G., et al.
Publicado: (2022)

Atherosclerosis as Mitochondriopathy: Repositioning the Disease to Help Finding New Therapies
por: Shemiakova, Taisiia, et al.
Publicado: (2021)

Zonisamide Enhances Motor Effects of Levodopa, Not of Apomorphine, in a Rat Model of Parkinson's Disease
por: Nishijima, Haruo, et al.
Publicado: (2018)

Behavioral effects of zonisamide on L-DOPA-induced dyskinesia in Parkinson's disease model mice
por: Sano, Hiromi, et al.
Publicado: (2023)

Zonisamide Administration Improves Fatty Acid β-Oxidation in Parkinson’s Disease
por: Ueno, Shin-Ichi, et al.
Publicado: (2018)

Comparative whole transcriptome analysis of Parkinson’s disease focusing on the efficacy of zonisamide
por: Naito, Tatsuhiko, et al.
Publicado: (2022)

Polysomnographic and Clinical Parameters before and after Zonisamide Therapy for Parkinson's Disease
por: Miyaue, Noriyuki, et al.
Publicado: (2022)

Using Spontaneous Eye-blink Rates to Predict the Motor Status of Patients with Parkinson's Disease
por: Iwaki, Hirotaka, et al.
Publicado: (2019)

Paradoxical Inhibition of Glycolysis by Pioglitazone Opposes the Mitochondriopathy Caused by AIF Deficiency
por: Bénit, Paule, et al.
Publicado: (2017)

Zonisamide: A review of the clinical and experimental evidence for its use in Parkinson's disease
por: Grover, Neeta D., et al.
Publicado: (2013)

Zonisamide in the management of epilepsy in the elderly
por: Romigi, Andrea, et al.
Publicado: (2015)

Zonisamide for the Efficacy of Sleep Abnormality in Parkinson's Disease (ZEAL Study): A Protocol for Randomized Controlled Trials
por: Kataoka, Hiroshi, et al.
Publicado: (2021)

Falling After Starting Running in a Case of Myoclonus Epilepsy Associated with Ragged-red Fibers with a 8344A>G mtDNA Mutation
por: Miyaue, Noriyuki, et al.
Publicado: (2018)

Phenotypic Diversity of Myoclonus Epilepsy Associated with Ragged-red Fibers with an 8344A>G mtDNA Mutation
por: Miyaue, Noriyuki, et al.
Publicado: (2019)

Zonisamide Ameliorates Cognitive Impairment by Inhibiting ER Stress in a Mouse Model of Type 2 Diabetes Mellitus
por: He, Yong-Xiang, et al.
Publicado: (2020)

Biallelic mutations in the ferredoxin reductase gene cause novel mitochondriopathy with optic atrophy
por: Peng, Yanyan, et al.
Publicado: (2017)

Biallelic mutations in the ferredoxin reductase gene cause novel mitochondriopathy with optic atrophy
por: Peng, Yanyan, et al.
Publicado: (2018)

Reticular Dysgenesis and Mitochondriopathy Induced by Adenylate Kinase 2 Deficiency with Atypical Presentation
por: Ghaloul-Gonzalez, Lina, et al.
Publicado: (2019)

Mitochondriopathy Manifesting as Inherited Tubulointerstitial Nephropathy Without Symptomatic Other Organ Involvement
por: Buglioni, Alessia, et al.
Publicado: (2021)

SARS-CoV-2 mitochondriopathy in COVID-19 pneumonia exacerbates hypoxemia
por: Archer, Stephen L., et al.
Publicado: (2022)

SARS-CoV-2 Mitochondriopathy in COVID-19 Pneumonia Exacerbates Hypoxemia
por: Archer, Stephen
Publicado: (2022)

Impact of Pregnancy on Zonisamide Pharmacokinetics in Rabbits
por: Matar, Kamal M.
Publicado: (2013)

Repositioning again of zonisamide for nerve regeneration
por: Ohno, Kinji, et al.
Publicado: (2016)

Zonisamide-induced acute kidney injury
por: Dixit, Deepali, et al.
Publicado: (2015)

Efficacy of Zonisamide in Migraineurs with Nonresponse to Topiramate
por: Chung, Jin-Young, et al.
Publicado: (2014)

Zonisamide-Induced Hallucinations: An Anticonvulsant’s Psychosis
por: Al Armashi, Abdul Rahman, et al.
Publicado: (2021)

Zonisamide Attenuates α-Synuclein Neurotoxicity by an Aggregation-Independent Mechanism in a Rat Model of Familial Parkinson’s Disease
por: Arawaka, Shigeki, et al.
Publicado: (2014)

MPC2 variants disrupt mitochondrial pyruvate metabolism and cause an early-onset mitochondriopathy
por: Pujol, Claire, et al.
Publicado: (2022)

Adjunct zonisamide to levodopa for DLB parkinsonism: A randomized double-blind phase 2 study
por: Murata, Miho, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_n9g8n2b43b4dd4n8iob5hdg0lf